We have located links that may give you full text access.
Magnetic Iron Oxide Nanoparticles as T 2 MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell.
Avicenna Journal of Medical Biotechnology 2017 October
BACKGROUND: Advances of nanotechnology have led to the development of nano-materials with both potential diagnostic and therapeutic applications. Among them, Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) have received particular attention. Modified EDC coupling fraction was used to fabricate the SPION-C595 as an MR imaging contrast agent for breast cancer detection in early stages.
METHODS: Nanoprobe characterization was confirmed using Fourier Transform Infrared Spectroscopy (FT-IR), Scanning Electron Microscopy with Energy Dispersive X-Ray Spectroscopy (SEM-EDAX), and Photon Correlation Spectroscopy (PCS). Protein and iron concentration of nanoprobe was examined by standard method. MTT assay was performed to evaluate the cytotoxicity of the nanoprobe in breast cancer cell line (MCF-7). T2 -weighted MR imaging was performed to evaluate the signal enhancement on T2 relaxation time of nanoprobe using spin-echo pulse sequence.
RESULTS: As results showed, SPIONs-C595 provided active targeting of breast cancer cell (MCF-7) at a final concentration of 600 μgFe/ml . The final concentration of protein was calculated to be at 0.78 μgprotein/ml . The hydrodynamic size of the nanoprobe was 87.4±0.7 nm . The MR imaging results showed a good reduction of T2 relaxation rates for the highest dose of SPIONs-C595.
DISCUSSION: Based on the results, SPIONs-C595 nanoprobe has a potential in T2 -weighted MR imaging contrast agent for breast cancer cell (MCF-7) detection.
METHODS: Nanoprobe characterization was confirmed using Fourier Transform Infrared Spectroscopy (FT-IR), Scanning Electron Microscopy with Energy Dispersive X-Ray Spectroscopy (SEM-EDAX), and Photon Correlation Spectroscopy (PCS). Protein and iron concentration of nanoprobe was examined by standard method. MTT assay was performed to evaluate the cytotoxicity of the nanoprobe in breast cancer cell line (MCF-7). T2 -weighted MR imaging was performed to evaluate the signal enhancement on T2 relaxation time of nanoprobe using spin-echo pulse sequence.
RESULTS: As results showed, SPIONs-C595 provided active targeting of breast cancer cell (MCF-7) at a final concentration of 600 μgFe/ml . The final concentration of protein was calculated to be at 0.78 μgprotein/ml . The hydrodynamic size of the nanoprobe was 87.4±0.7 nm . The MR imaging results showed a good reduction of T2 relaxation rates for the highest dose of SPIONs-C595.
DISCUSSION: Based on the results, SPIONs-C595 nanoprobe has a potential in T2 -weighted MR imaging contrast agent for breast cancer cell (MCF-7) detection.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app